Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

FDA accepts sNDA for Dacogen in acute myeloid leukemia

July 14, 2011

High-dose EPIAO approved in China to treat chemotherapy-associated anemia

July 14, 2011

Treatment begins in Cerulean Pharma's phase II CRLX-101 study in NSCLC

July 14, 2011

Novel PKB inhibitors presented

July 14, 2011

Dehydro-alpha-lapachone is natural antiangiogenic product that targets cell adhesion

July 14, 2011

DMC completes data review from 535 participants of phase III trial HEAT

July 13, 2011

Micromet and Amgen form BiTE antibody collaboration

July 13, 2011

Gamida Cell-Teva joint venture clear to continue accrual in phase III StemEx trial

July 13, 2011

Sunshine Biopharma's Adva-27a effectively kills multidrug-resistant breast cancer cells in vitro

July 13, 2011

Axelar completes phase I/II safety study of AXL-1717 in solid tumors

July 13, 2011

Popular Stories

Today's news in brief
BioWorld
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...